Bristol Myers Squibb CEO Christopher Boerner joins 'Mad Money' host Jim Cramer to talk its new schizophrenia treatment Cobenfy, its oncology business, and more. South Korea's impeached President ...
(Pediatric Research) Could the largest market for the new schizophrenia drug xanomeline and trospium chloride (Cobenfy) be in Alzheimer's disease psychosis, agitation, and cognition? Bristol Myers ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback